Gino Gerosa

Plain English
This study focused on improving how doctors diagnose heart transplant rejection using a new genetic testing method. By analyzing samples from heart transplant patients, researchers discovered that their method accurately identified cases of antibody-mediated rejection (AMR) and acute cellular rejection (ACR). They achieved an accuracy of about 81% for AMR and 85% for ACR, which helps to more effectively determine when a transplant is being rejected and improve patient care. Who this helps: This benefits heart transplant patients and their doctors by providing a clearer diagnosis and guiding treatment decisions.

Plain English
This study examined how vancomycin resistance affects the risk of dying within 30 days for transplant patients with serious bloodstream infections. Out of 79 patients studied, 12.7% died in that timeframe, with septic shock being the biggest predictor of mortality, showing a much higher risk (over 11 times more likely to die) than other factors. The research highlights the importance of quickly identifying and treating septic shock rather than focusing primarily on antibiotic resistance. Who this helps: This helps patients who have undergone organ transplants and their medical teams.

Plain English
This study looked at a new technique for repairing the mitral valve in patients who had previously undergone heart surgery and experienced recurring issues. Researchers treated 92 patients using the NeoChord technique, achieving a high success rate of almost 99% in fixing severe mitral regurgitation. At the five-year mark, 81.3% of patients had no major issues, making this a safe and effective option for those needing a second procedure. Who this helps: This helps heart patients, particularly those with a history of mitral valve issues.

Plain English
This study looked at how suitable two different devices are for repairing a part of the aorta in patients who had previous surgery for a serious heart condition called Type A aortic dissection. Out of 465 patients who had surgery, 119 (about 26%) were assessed, and about half of them (59 patients, or 50%) were found to be eligible for one of the devices. However, many patients were deemed ineligible because factors from their previous surgeries, like poorly placed or short grafts, hindered their options. Who this helps: This research benefits patients recovering from aortic surgery by identifying better repair methods.

Plain English
Researchers studied a way to create a new type of heart scaffold from pig heart tissue that could help fix problems with current heart devices. They found that their method successfully removed cells while keeping the important structure and materials needed for heart pacing intact. This is significant because it could lead to better heart replacements that work with the body more naturally and effectively. Who this helps: This benefits patients with heart issues who need safer and more effective treatments.

Plain English
This study looked at two young patients with a rare disease called juvenile-onset systemic sclerosis, which can severely affect the heart. Both patients had serious heart problems that did not get better with regular treatments, leading to successful heart transplants; one had severe heart damage and the other had heart issues despite managing other symptoms well. The findings show that heart transplantation can be a crucial option for selected patients with severe heart involvement from this disease, potentially saving lives. Who this helps: This helps young patients with systemic sclerosis and their doctors in making treatment decisions.

Plain English
This study looked at adult patients with congenital heart disease who needed heart transplants and how additional surgical repairs during the transplant affected their recovery. Out of 40 patients analyzed, 17 needed extra repairs, while 8 (20%) died within 30 days after surgery, but the type of extra repair did not change the risk of death either right after or many years after the operation. This matters because it helps doctors understand that these additional surgeries might not impact long-term survival, which can inform treatment choices for this complex patient group. Who this helps: This helps patients with congenital heart disease and their doctors by providing insights into the surgical approaches during heart transplantation.

Plain English
This research looks at how to improve the process of obtaining informed consent and making shared decisions between doctors and patients in heart care. The study highlights that many current practices are unclear and often overlook the specific needs of vulnerable groups, which can put patients at risk. It proposes a three-step method for enhancing this process, including using artificial intelligence to help patients understand their options better and ensuring that consent is properly obtained and respects patient choices. Who this helps: This benefits patients, especially those with heart conditions and vulnerable populations needing clear guidance in their care decisions.

Plain English
This study looked at heart transplants from donors who were declared dead after their hearts stopped beating in Italy. Between May 2023 and December 2024, 40 heart transplants were performed from these donors, who had an average warm ischemia time (the time the heart was without blood flow) of about 43 minutes. The results were promising, with a 30-day survival rate of 90% and a good average heart function at discharge. Who this helps: This research benefits patients in need of a heart transplant, especially those with fewer donor options.

Plain English
This study focused on a new approach to implant a pulmonary valve in patients considered very high-risk for traditional surgery. Researchers described a case where a 59-year-old patient with a large heart condition received a Harmony valve using a combination of mini-invasive surgical techniques and traditional methods. The surgery went smoothly, and the patient's heart function improved significantly, changing from a serious level of heart failure to a much better one. Who this helps: This benefits high-risk patients who need heart valve replacement but cannot undergo standard surgical procedures.

Plain English
This study looked at a new type of heart valve called polymeric heart valves (PHVs) to see if they could be a better option than existing prosthetic heart valves. The researchers found that while PHVs might combine the strength of mechanical valves with the safety of bioprosthetic ones, they still face issues like limited compatibility with the body and risks of failure. However, they believe PHVs could greatly improve heart valve replacement methods in the future, especially for patients undergoing less invasive procedures. Who this helps: This helps patients with heart valve diseases looking for safer and more durable treatment options.

Plain English
This study looked at a risk score called the GERAADA score, which predicts the risk of dying within 30 days after surgery for a severe condition called type A acute aortic dissection. Researchers found that the GERAADA score estimated a higher expected death rate of 18.4% compared to the EuroSCORE II, which estimated only 5.8%. These findings suggest that GERAADA may be better at accurately predicting outcomes for these surgeries, which is important because it can help doctors better assess risks for patients. Who this helps: This helps doctors by providing a more accurate tool for assessing the risks of surgery in patients with type A acute aortic dissection.

Plain English
This study looked at how well experts can predict a problem called prosthesis-patient mismatch (PPM) after patients have surgery to replace a heart valve. The researchers analyzed data from 872 patients and found that in about 73% of the cases, the predicted mismatch matched what was actually measured after surgery. However, the predictions were not very reliable, especially for smaller valve sizes, which means doctors should be careful when assessing smaller replacements. Who this helps: This helps patients undergoing aortic valve replacement and their doctors.

Plain English
This study examined the heart function of 345 heart transplant patients over an 11-year period to see how it related to their long-term survival. Researchers found that higher pressure measurements (arterial elastance) and lower heart performance measures (left ventricular end-systolic elastance) were linked to a greater risk of death; specifically, patients with high arterial elastance were 2.25 times more likely to die, and those with low left ventricular end-systolic elastance were 3.7 times more likely. These findings matter because they help identify patients who may need closer monitoring and intervention after their heart transplant. Who this helps: This helps patients and doctors managing care after heart transplantation.

Plain English
This study looked at new ways to preserve heart tissue used in transplants, which are critical for treating severe heart diseases. The current methods are limited by tissue availability and how long the grafts last, with the traditional cold storage not always protecting the tissue well. The research highlighted promising techniques like vitrification and decellularization to maintain tissue viability longer and reduce rejection rates, ultimately aiming to create more reliable heart grafts for patients. Who this helps: This benefits patients needing heart transplants and doctors looking for better treatment options.

Plain English
This study looked at how specific genes and small RNA molecules behave in heart transplant patients who get infected with cytomegalovirus (CMV) compared to those experiencing acute cellular rejection (ACR). Researchers found that two genes (IL7R and GZMK) and two miRNAs (mir-93-5p and mir-345-5p) were present in different amounts in CMV-infected patients, allowing them to distinguish between infection and rejection with 91% accuracy. This matters because it offers a new way to quickly identify CMV infections in heart transplant patients, which can lead to better treatment and outcomes. Who this helps: This helps heart transplant patients and their doctors.

Plain English
This study looks at the use of drugs for heart xenotransplantation, which is the process of transplanting animal hearts into humans, as a solution to the shortage of human heart donors in Europe. Researchers reviewed the drugs used so far in these procedures and found many are not approved specifically for this type of transplant, but their effects could still help prevent the body from rejecting the new heart. This research matters because understanding which medications can be utilized may lead to better treatment options for patients awaiting heart transplants, especially in light of limited human organ availability. Who this helps: Patients with end-stage heart disease who need a transplant.

Plain English
This study looked at how severe calcification of the heart's mitral valve area (called mitral annulus calcification or MAC) affects patients with aortic stenosis who are undergoing surgery to replace their heart valve. Among 313 patients, 12.1% had severe MAC, which was linked to a higher risk of serious heart problems and death over five years. This finding is important because it can help doctors better assess risks and improve care for patients needing valve replacement. Who this helps: This helps patients undergoing aortic valve replacement and their doctors by providing better risk assessment information.

Plain English
This study explored whether tiny particles called extracellular vesicles (EVs) can provide an easier way to detect heart transplant rejection (specifically, acute cellular rejection or ACR) using blood samples instead of invasive procedures like biopsies. Researchers found that 14 specific markers on these EVs increased as rejection severity rose, showing changes even before traditional diagnoses could. Their AI model accurately identified ACR in 93.3% of cases, offering a promising noninvasive method for early detection and better management of heart transplant patients. Who this helps: Heart transplant patients and their doctors.

Plain English
This study looked at new, less invasive surgery options for treating atrial fibrillation, a common heart rhythm problem that often affects older people and can lead to serious complications like strokes. The researchers found that techniques such as mini-thoracotomy and thoracoscopic ablation are effective in restoring normal heart rhythm while causing less trauma and fewer complications than traditional open surgery. These methods can also help prevent strokes by closing off a part of the heart that can form dangerous blood clots. Who this helps: This benefits patients with atrial fibrillation, especially those who have not responded well to other treatments.

Plain English
This study looked at heart transplantation from donors who have experienced circulatory death, using a method called machine perfusion to improve the quality of the donated hearts. The research found that using this machine can help preserve hearts and lead to survival rates and rejection rates similar to those seen in heart transplants from brain-dead donors. This is important because it increases the number of viable donor hearts and improves the chances of successful transplants. Who this helps: This helps patients in need of a heart transplant.

Plain English
This study looked at how well the GERAADA score can predict long-term survival rates for patients who had surgery for a serious condition called acute type A aortic dissection. They analyzed data from 1,110 patients and found that the survival rates after 5 years were about 62.5% and after 10 years about 48.5%. However, the GERAADA score did not do a great job of predicting survival outcomes over the long term. Who this helps: This information is useful for doctors and patients considering surgery for aortic dissection.

Plain English
This study looked at heart transplant patients to see how a specific condition called afterload mismatch (AM) affects their long-term heart health. Researchers found that patients with AM had a lower heart function (57% compared to 63% and 64% in other groups) and a shorter survival time, with an average of 17.2 years for those with AM compared to 27.8 years for one other group. Importantly, having AM made patients more than twice as likely to die from heart-related issues. Who this helps: This research benefits heart transplant patients and their doctors by highlighting risks that can affect survival after the procedure.

Plain English
This study looked at how patients waiting for heart transplants did when they were supported by inotropes, a type of medication that helps the heart pump better, compared to those using other support methods like ECMO or VADs. It found that among almost 12,000 patients, those on inotropes had lower mortality rates at 30 days (3.5% vs. 14% for ECMO) and 1 year, as well as better long-term survival rates over 10 years, showing a significantly lower risk of death compared to those on other methods. This matters because it highlights that inotropes can be a safer option for patients awaiting heart transplants when mechanical support is not available. Who this helps: Patients waiting for heart transplants.

Plain English
This study explored new hybrid materials made by combining natural and synthetic components to see how well they can be used in medicine. Researchers created membranes from pig heart tissue and a synthetic material, tested their abilities in the lab, and conducted experiments in rats. They found that the hybrid membranes integrated better with body tissue and showed no harmful effects, with better performance after 8 weeks than using just the synthetic material, making them promising for future medical applications. Who this helps: Patients needing implants or tissue engineering solutions.

Plain English
This study compared two types of heart valves used in patients with small aortic openings: rapid deployment (RD) valves and conventional stented valves. Researchers found that RD valves had better blood flow results (with lower average pressure gradients of 12 mmHg, compared to 16 mmHg for conventional valves), but both types of valves showed similar rates of complications, survival, and hospital readmissions after five years. This matters because it indicates that while RD valves may improve blood flow, both options are equally effective in terms of long-term health outcomes. Who this helps: Patients with small aortic annuli needing valve replacement.

Plain English
This study examined how future climate change might affect the risk of ozone damage to wheat crops worldwide. Researchers found that ozone risk is likely to decrease overall from 3.3-5.0% production loss at the beginning of the century to less than 1.4% by 2100 under a strong environmental policy scenario. However, in areas with weaker policies, such as parts of Asia and Africa, production losses could remain between 1.3% and 4.9%. Who this helps: This research benefits farmers and agricultural policymakers aiming to protect wheat crops from air pollution.

Plain English
This study looked at heart transplant outcomes for patients aged 65 and older compared to those younger than 65. Researchers found that older patients (73 in total) had a higher risk of complications after surgery and a higher chance of dying in the hospital, with 28.8% experiencing in-hospital mortality. Over a follow-up period of about 4 years, only 68% of older patients were still alive after one year, and only 62% after five years, indicating that heart transplants are riskier for older adults, but addressing certain factors like donor age may improve their outcomes. Who this helps: This research helps doctors and healthcare providers as they make decisions about heart transplants for older patients.

Plain English
This study looked at patients with severe heart failure who received a left ventricular assist device (LVAD) and whether doing tricuspid valve surgery at the same time affected their outcomes. Researchers analyzed data from 2,206 patients and found that while doing both surgeries didn’t change the risk of dying shortly after the procedure, those who had both surgeries had a higher chance (36% more) of needing an additional device to support the right side of the heart. They also discovered that patients who had the tricuspid valve surgery alongside the LVAD had a higher risk of dying in the long run. Who this helps: This information is useful for doctors treating patients with advanced heart failure.

Plain English
This study looked at how using a special type of CT scan before a procedure called transvenous lead extraction (TLE) can help predict difficulties and complications during the procedure. Researchers found that complicated procedures happened in about 21% of patients, and those with fibrosis (scarring) longer than 40 mm on the CT scan were more likely to face complications. Additionally, 37% of procedures were deemed complex, with longer fibrosis lengths and lead calcifications making these procedures more challenging. The findings demonstrate that CT scans can help doctors assess risks and plan better for TLE procedures. Who this helps: This helps doctors and patients undergoing TLE by improving safety and outcomes.

Plain English
This study compared two methods of storing donor hearts before transplantation: the traditional static cold storage (SCS) and a new technique called hypothermic oxygenated machine perfusion (HOPE). Out of 204 patients who received a transplant, the HOPE method resulted in fewer heart complications, with only 19% experiencing serious problems compared to 30% with SCS, which is a 44% lower risk of complications. This is important because it shows that using HOPE can lead to better outcomes for patients who receive a transplanted heart. Who this helps: This helps patients needing heart transplants by potentially reducing complications and improving success rates.

Plain English
The study focuses on a new heart valve called the mitris RESILIA valve, designed to combine the best features of two existing valves for better performance and durability. Researchers found that this new valve has a flexible design that helps it fit better in the heart, which could reduce the risk of complications during surgery. It also has a technology that may help it last longer without breaking down, making it a promising option for patients needing valve replacement. Who this helps: This benefits patients undergoing heart valve replacement surgeries.

Plain English
This study looked at three types of aortic valves used in heart surgery: Magna Ease, Intuity, and Inspiris. Researchers analyzed data from 2,589 patients and found that the Intuity valve had the shortest surgery time and all valves had good early outcomes. Importantly, the Inspiris valve had a much lower rate of needing a permanent pacemaker (2%) compared to the other valves (6%), and its performance was as good as the rapid-deployment valves. Who this helps: This information benefits patients needing heart surgery and their doctors by guiding them toward the best valve options.

Plain English
This study looked at heart transplants from donors who died due to stopped circulation (DCD) and compared them with heart transplants from donors who died after brain death (DBD). The research found that both groups had similar survival rates at one year, with 91.1% for DCD and 90.1% for DBD patients, showing that transplants from DCD donors can be just as effective. This matters because it opens up new opportunities for heart donations, potentially helping even more patients in need of a transplant. Who this helps: Patients needing heart transplants.

Plain English
This research looked at how well the Impella device helps patients with post-infarct ventricular septal defect, a serious heart condition. The study reviewed 20 papers involving 68 patients who had the Impella implanted before treatment; over 95% were in cardiogenic shock and half were already using other heart support devices. The findings revealed that 47% of patients died in the hospital, but those with the Impella implanted during surgery had lower mortality rates (35%) compared to those who received it in a less invasive way (58%). Understanding how Impella works in these patients is crucial as it can stabilize their condition and improve treatment outcomes. Who this helps: This benefits patients with severe heart conditions, especially those recovering from a heart attack.

Plain English
This study looked at how malnutrition affects heart transplant patients. Researchers evaluated 168 patients and found that while malnutrition scores (measured by the MUST tool) did not increase the risk of complications or death right after the surgery, higher malnutrition scores were linked to a greater risk of dying later on, with a hazard ratio of 1.28. Understanding this relationship is important because it highlights the need to address malnutrition in heart transplant patients to potentially improve their long-term survival. Who this helps: This helps patients undergoing heart transplants and their doctors managing their nutritional health.

Plain English
This study focuses on a 75-year-old man in Italy who developed endocarditis, a serious heart infection. He experienced symptoms like shortness of breath and weight loss and was treated with antibiotics and surgery. The researchers also looked at 12 other cases documented worldwide, highlighting the need for better understanding and detection of this condition. Who this helps: This helps doctors treat patients with endocarditis more effectively.

Plain English
This study examined a successful heart transplant from a donor who had died from a lack of blood flow (circulatory death), despite the heart being without blood for 43 minutes. The researchers used a special transport system to keep the heart cold during transportation, which helped it recover well after the transplant. This case shows that even with longer waiting times before organ removal, it’s possible to use these hearts for transplants, potentially increasing the number of available donor hearts in countries with strict regulations. Who this helps: This benefits patients on waiting lists for heart transplants.